Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mahesh Subramanian, Gajanan J. Chintalwar & Subrata Chattopadhyay. (2021) Iron modulatory property of a polysaccharide from Indian medicinal plant Ocimum sanctum. Free Radical Research 55:8, pages 758-767.
Read now
Read now
Mohammed A. Alali, Khalid M.A. Alanazi, Sarah N. Alsayil, Zakaria Omari & Ali Shaaban. (2020) Calcium Channel Blockers in Conjunction with Standard Iron-Chelating Agents for β-Thalassemia Major: Systematic Literature Search. Hemoglobin 44:6, pages 446-450.
Read now
Read now
George J Kontoghiorghes. (2013) The Proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies. Toxicology Mechanisms and Methods 23:1, pages 1-4.
Read now
Read now
Jaroslav Cermak, Anna Jonasova, Jana Vondrakova, Lenka Walterova, Ivana Hochova, Magda Siskova & Radana Neuwirtova. (2011) Efficacy And Safety Of Administration Of Oral Iron Chelator Deferiprone In Patients With Early Myelodysplastic Syndrome. Hemoglobin 35:3, pages 217-227.
Read now
Read now
George J. Kontoghiorghes. (2011) A Record Of 1320 Suspect, Deferasirox-Related, Patient Deaths Reported In 2009: Insufficient Toxicity Testing, Low Efficacy And Lack Of Transparency May Endanger The Lives Of Iron Loaded Patients. Hemoglobin 35:3, pages 301-311.
Read now
Read now
Annita Kolnagou, Marios Kleanthous & George J. Kontoghiorghes. (2011) Efficacy, Compliance And Toxicity Factors Are Affecting The Rate Of Normalization Of Body Iron Stores In Thalassemia Patients Using The Deferiprone And Deferoxamine Combination Therapy. Hemoglobin 35:3, pages 186-198.
Read now
Read now
Articles from other publishers (16)
Lars Gerhardsson. 2022. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
663
684
.
Muhammed Khaled Elfaituri, Sherief Ghozy, Amr Ebied, Mostafa Ebraheem Morra, Osama Gamal Hassan, Ahmed Alhusseiny, Alzhraa Salah Abbas, Nourin Ali Sherif, Juliano Lara Fernandes & Nguyen Tien Huy. (2021) Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta‐analysis and simulation of future studies. Vox Sanguinis 116:8, pages 887-897.
Crossref
Crossref
Hossein Karami, Hadiseh Khalilzadeh Arjmandi, Ebrahim Salehifar, Hadi Darvishi‐Khezri, Mojdeh Dabirian, Mehrnoush Kosaryan, Aily Aliasgharian, Rosetta Akbarzadeh, Raheleh Naeimayi Aali & Amirreza Nasirzadeh. (2021) A double‐blind, controlled, crossover trial of amlodipine on iron overload status in transfusion dependent β‐thalassemia patients. International Journal of Clinical Practice 75:8.
Crossref
Crossref
Aziz Eghbali, Pooria Shokri, Roghayeh Rahimi Afzal & Bahador Bagheri. (2019) A 1-year randomized trial of deferasirox alone versus deferasirox and deferoxamine combination for the treatment of iron overload in thalassemia major. Transfusion and Apheresis Science 58:4, pages 429-433.
Crossref
Crossref
Saher KhalafAbdullah Shafique AhmadK.V.D. Ranga ChamaraSylvain Doré. (2019) Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma. Journal of Neurotrauma 36:1, pages 43-53.
Crossref
Crossref
Aziz Eghbali, Hamideh Kazemi, Hassan Taherahmadi, Yazdan Ghandi, Mohammad Rafiei & Bahador Bagheri. (2017) A randomized, controlled study evaluating effects of amlodipine addition to chelators to reduce iron loading in patients with thalassemia major. European Journal of Haematology 99:6, pages 577-581.
Crossref
Crossref
Somayeh Kalanaky, Maryam Hafizi, Sepideh Safari, Kazem Mousavizadeh, Mahboubeh Kabiri, Alireza Farsinejad, Saideh Fakharzadeh & Mohammad Hassan Nazaran. (2016) TLc-A, the leading nanochelating-based nanochelator, reduces iron overload in vitro and in vivo. International Journal of Hematology 103:3, pages 274-282.
Crossref
Crossref
Yoshiro Naito, Aya Fujii, Hisashi Sawada, Makiko Oboshi, Toshihiro Iwasaku, Yoshitaka Okuhara, Daisuke Morisawa, Akiyo Eguchi, Shinichi Hirotani & Tohru Masuyama. (2015) Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease. Hypertension Research 38:7, pages 463-470.
Crossref
Crossref
M Amélia Santos & Sílvia Chaves. (2015) 3-hydroxypyridinone derivatives as metal-sequestering agents for therapeutic use. Future Medicinal Chemistry 7:3, pages 383-410.
Crossref
Crossref
Lars Gerhardsson & George Kazantzis. 2015. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
487
505
.
Christina N Kontoghiorghe. (2014) World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients. World Journal of Methodology 4:3, pages 163.
Crossref
Crossref
Juliano Lara Fernandes, Erika Fontana Sampaio, Kleber Fertrin, Otavio Rizzi Coelho, Sandra Loggetto, Antonio Piga, Monica Verissimo & Sara T. Saad. (2013) Amlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial. The American Journal of Medicine 126:9, pages 834-837.
Crossref
Crossref
Juliano Lara Fernandes. (2012) Iron chelation therapy in the management of transfusion-related cardiac iron overload. Transfusion 52:10, pages 2256-2268.
Crossref
Crossref
Sunil Bhandari & Renzo Galanello. (2012) Renal aspects of thalassaemia a changing paradigm. European Journal of Haematology 89:3, pages 187-197.
Crossref
Crossref
M. Amélia Santos, Sérgio M. Marques & Sílvia Chaves. (2012) Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs. Coordination Chemistry Reviews 256:1-2, pages 240-259.
Crossref
Crossref
Efthimia VlachakiK. Chatzinikolaou, E. Bekiari, F. Klonizakis & A. Tsapas. (2011) Is Deferasirox Implicated in Multiple Organ Failure in a Patient With Homozygous β-Thalassemia?. Angiology 62:4, pages 346-348.
Crossref
Crossref